Haemonetics Corporation (HAE) Q1 2021 Earnings Results

Haemonetics Corp Misses on EPS — Stock Down 12.41%

Haemonetics Corp's earnings report showed a significant miss on EPS, leading to a 12.41% drop in stock price. The company did not provide revenue figures or future guidance, which may have contributed to investor uncertainty. Management's cautious tone suggests they are navigating challenges in the market, which could affect performance in the near term.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.21	N/A	-48.15%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about the impact of market conditions on performance. They remain focused on strategic initiatives but did not provide specific guidance.

Management acknowledged challenges in the current market environment.

They emphasized a focus on long-term strategies despite short-term setbacks.

Haemonetics Corp Misses on EPS — Stock Down 12.41%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Misses on EPS — Stock Down 12.41%

Key numbers

Management commentary